These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Pacheco AR; Sperandio V Front Cell Infect Microbiol; 2012; 2():81. PubMed ID: 22919672 [TBL] [Abstract][Full Text] [Related]
6. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7. Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709 [TBL] [Abstract][Full Text] [Related]
8. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779 [TBL] [Abstract][Full Text] [Related]
9. Production of egg yolk antibody (IgY) against a chimeric protein containing IpaD, StxB, and TolC antigens from Shigella: An investigation of its prophylactic effects against Shiga toxin (Stx) and Hadi N; Nazarian S; Rouhi S; Hosseini SE; Fathi J Heliyon; 2024 Feb; 10(4):e26361. PubMed ID: 38404796 [No Abstract] [Full Text] [Related]
10. Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes. Garimano N; Diaz Vergara LI; Kim AD; Badin EE; Sodero S; Bernal AM; Gonzalez DD; Amaral MM; Lespinard AR; Porporatto C; Montenegro MA; Palermo MS; Larzabal M; Cataldi AA; Ibarra C; Sacerdoti F J Dairy Sci; 2021 May; 104(5):5229-5238. PubMed ID: 33685676 [TBL] [Abstract][Full Text] [Related]
11. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Roxas JL; Koutsouris A; Bellmeyer A; Tesfay S; Royan S; Falzari K; Harris A; Cheng H; Rhee KJ; Hecht G Lab Invest; 2010 Aug; 90(8):1152-68. PubMed ID: 20479715 [TBL] [Abstract][Full Text] [Related]
12. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity. Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033 [TBL] [Abstract][Full Text] [Related]
13. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613 [TBL] [Abstract][Full Text] [Related]
14. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice. Barati B; Ebrahimi F; Nazarian S Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232 [TBL] [Abstract][Full Text] [Related]
15. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7. Sanchez-Villamil JI; Tapia D; Torres AG mBio; 2019 Aug; 10(4):. PubMed ID: 31409688 [TBL] [Abstract][Full Text] [Related]
16. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated]. Liu J; Sun Y; Feng SZ Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890 [TBL] [Abstract][Full Text] [Related]
17. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization. Tapia D; Ross BN; Kalita A; Kalita M; Hatcher CL; Muruato LA; Torres AG Front Cell Infect Microbiol; 2016; 6():94. PubMed ID: 27625996 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698 [TBL] [Abstract][Full Text] [Related]
19. Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates. Li R; Harada T; Honjoh K; Miyamoto T Microb Pathog; 2010 Nov; 49(5):246-51. PubMed ID: 20558273 [TBL] [Abstract][Full Text] [Related]
20. Recombinant Shiga toxin B subunit can induce neutralizing immunoglobulin Y antibody. Neri P; Tokoro S; Sugiyama T; Umeda K; Shimizu T; Tsuji T; Kodama Y; Mori H Biol Pharm Bull; 2012; 35(6):917-23. PubMed ID: 22687484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]